Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.1016/j.preghy.2019.03.011 http://hdl.handle.net/11449/189700 |
Resumo: | Introduction: Preeclampsia affects 3–5% of pregnancies worldwide and is the primary cause of maternal-fetal and neonatal mortality. Previous studies show that alterations in maternal concentrations of angiogenic factors, such as PlGF, PDGF AA, ANG-1, and ANG-2, may play fundamental roles in the pathophysiology of the disease. Objective: Determine whether the PlGF, PDGF AA, ANG-1, and ANG-2 are predictors of preeclampsia occurrence in a prenatal cohort study. Patients and methods: This is a case-control study associated with a prospective cohort of pregnant women, with gestational ages between 20 and 25 weeks, composed of 30 pregnant women with preeclampsia (PE) and 90 healthy pregnant women (HP). The plasma concentrations of the markers were determined using the ELISA method. The comparison between the case and control groups was performed using the t test on the SAS® 9.4 software. Also, ROC curves were constructed to evaluate the predictive potential of the biomarkers. Results: Differences in the concentrations of PlGF, PDGF AA, ANG-1 and ANG-2, and the ANG-1/ANG-2 ratio were not observed between the PE and the HP groups. The predictive capacity of the biomarkers was assessed using ROC curves, in which the area under the curve for PlGF AUC = 0.55; PDGF AA AUC = 0.55; ANG-1 AUC = 0.47; ANG-2 AUC = 0.51, and the ANG-1/ANG-2 ratio AUC = 0.57. Conclusion: In pregnant women, with gestational ages between 20 and 25 weeks significant differences in biomarker concentrations between groups PE and HP were not observed. The ROC curves showed that the biomarkers were ineffective as preeclampsia predictors in the analyzed cohort. |
id |
UNSP_50d8a0173ed1c38e16d2d5a225fb8e22 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/189700 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant womenANG-1ANG-1/ANG-2ANG-2CohortPDGF AAPlGFPredictorsPreeclampsiaIntroduction: Preeclampsia affects 3–5% of pregnancies worldwide and is the primary cause of maternal-fetal and neonatal mortality. Previous studies show that alterations in maternal concentrations of angiogenic factors, such as PlGF, PDGF AA, ANG-1, and ANG-2, may play fundamental roles in the pathophysiology of the disease. Objective: Determine whether the PlGF, PDGF AA, ANG-1, and ANG-2 are predictors of preeclampsia occurrence in a prenatal cohort study. Patients and methods: This is a case-control study associated with a prospective cohort of pregnant women, with gestational ages between 20 and 25 weeks, composed of 30 pregnant women with preeclampsia (PE) and 90 healthy pregnant women (HP). The plasma concentrations of the markers were determined using the ELISA method. The comparison between the case and control groups was performed using the t test on the SAS® 9.4 software. Also, ROC curves were constructed to evaluate the predictive potential of the biomarkers. Results: Differences in the concentrations of PlGF, PDGF AA, ANG-1 and ANG-2, and the ANG-1/ANG-2 ratio were not observed between the PE and the HP groups. The predictive capacity of the biomarkers was assessed using ROC curves, in which the area under the curve for PlGF AUC = 0.55; PDGF AA AUC = 0.55; ANG-1 AUC = 0.47; ANG-2 AUC = 0.51, and the ANG-1/ANG-2 ratio AUC = 0.57. Conclusion: In pregnant women, with gestational ages between 20 and 25 weeks significant differences in biomarker concentrations between groups PE and HP were not observed. The ROC curves showed that the biomarkers were ineffective as preeclampsia predictors in the analyzed cohort.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Department of Gynecology and Obstetrics Ribeirão Preto Medical School University of São Paulo, 3900 Bandeirantes AvenueDepartment of Health Sciences Ribeirão Preto Medical School University of São Paulo, 3900 Bandeirantes AvenueDepartment of Pharmacology Biosciences Institute State University of São Paulo (UNESP)Department of Childcare and Pediatrics Ribeirão Preto Medical School University of São Paulo, 3900 Bandeirantes AvenueDepartment of Pharmacology Biosciences Institute State University of São Paulo (UNESP)FAPESP: FAPESPUniversidade de São Paulo (USP)Universidade Estadual Paulista (Unesp)Machado, J. S.R.Machado, M. S.R.Bertagnolli, T. V.Martins, L. A.B.Freitas, S. F.Ovidio, P. P.Sandrim, V. C. [UNESP]Cardoso, V. C.Bettiol, H.Barbieri, M. A.Cavalli, R. C.2019-10-06T16:49:20Z2019-10-06T16:49:20Z2019-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article105-111http://dx.doi.org/10.1016/j.preghy.2019.03.011Pregnancy Hypertension, v. 16, p. 105-111.2210-77972210-7789http://hdl.handle.net/11449/18970010.1016/j.preghy.2019.03.0112-s2.0-85063504912Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengPregnancy Hypertensioninfo:eu-repo/semantics/openAccess2024-09-03T13:46:51Zoai:repositorio.unesp.br:11449/189700Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T13:46:51Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
title |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
spellingShingle |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women Machado, J. S.R. ANG-1 ANG-1/ANG-2 ANG-2 Cohort PDGF AA PlGF Predictors Preeclampsia |
title_short |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
title_full |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
title_fullStr |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
title_full_unstemmed |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
title_sort |
Role of plasma PlGF, PDGF-AA, ANG-1, ANG-2, and the ANG-1/ANG-2 ratio as predictors of preeclampsia in a cohort of pregnant women |
author |
Machado, J. S.R. |
author_facet |
Machado, J. S.R. Machado, M. S.R. Bertagnolli, T. V. Martins, L. A.B. Freitas, S. F. Ovidio, P. P. Sandrim, V. C. [UNESP] Cardoso, V. C. Bettiol, H. Barbieri, M. A. Cavalli, R. C. |
author_role |
author |
author2 |
Machado, M. S.R. Bertagnolli, T. V. Martins, L. A.B. Freitas, S. F. Ovidio, P. P. Sandrim, V. C. [UNESP] Cardoso, V. C. Bettiol, H. Barbieri, M. A. Cavalli, R. C. |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Universidade Estadual Paulista (Unesp) |
dc.contributor.author.fl_str_mv |
Machado, J. S.R. Machado, M. S.R. Bertagnolli, T. V. Martins, L. A.B. Freitas, S. F. Ovidio, P. P. Sandrim, V. C. [UNESP] Cardoso, V. C. Bettiol, H. Barbieri, M. A. Cavalli, R. C. |
dc.subject.por.fl_str_mv |
ANG-1 ANG-1/ANG-2 ANG-2 Cohort PDGF AA PlGF Predictors Preeclampsia |
topic |
ANG-1 ANG-1/ANG-2 ANG-2 Cohort PDGF AA PlGF Predictors Preeclampsia |
description |
Introduction: Preeclampsia affects 3–5% of pregnancies worldwide and is the primary cause of maternal-fetal and neonatal mortality. Previous studies show that alterations in maternal concentrations of angiogenic factors, such as PlGF, PDGF AA, ANG-1, and ANG-2, may play fundamental roles in the pathophysiology of the disease. Objective: Determine whether the PlGF, PDGF AA, ANG-1, and ANG-2 are predictors of preeclampsia occurrence in a prenatal cohort study. Patients and methods: This is a case-control study associated with a prospective cohort of pregnant women, with gestational ages between 20 and 25 weeks, composed of 30 pregnant women with preeclampsia (PE) and 90 healthy pregnant women (HP). The plasma concentrations of the markers were determined using the ELISA method. The comparison between the case and control groups was performed using the t test on the SAS® 9.4 software. Also, ROC curves were constructed to evaluate the predictive potential of the biomarkers. Results: Differences in the concentrations of PlGF, PDGF AA, ANG-1 and ANG-2, and the ANG-1/ANG-2 ratio were not observed between the PE and the HP groups. The predictive capacity of the biomarkers was assessed using ROC curves, in which the area under the curve for PlGF AUC = 0.55; PDGF AA AUC = 0.55; ANG-1 AUC = 0.47; ANG-2 AUC = 0.51, and the ANG-1/ANG-2 ratio AUC = 0.57. Conclusion: In pregnant women, with gestational ages between 20 and 25 weeks significant differences in biomarker concentrations between groups PE and HP were not observed. The ROC curves showed that the biomarkers were ineffective as preeclampsia predictors in the analyzed cohort. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-10-06T16:49:20Z 2019-10-06T16:49:20Z 2019-04-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.preghy.2019.03.011 Pregnancy Hypertension, v. 16, p. 105-111. 2210-7797 2210-7789 http://hdl.handle.net/11449/189700 10.1016/j.preghy.2019.03.011 2-s2.0-85063504912 |
url |
http://dx.doi.org/10.1016/j.preghy.2019.03.011 http://hdl.handle.net/11449/189700 |
identifier_str_mv |
Pregnancy Hypertension, v. 16, p. 105-111. 2210-7797 2210-7789 10.1016/j.preghy.2019.03.011 2-s2.0-85063504912 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Pregnancy Hypertension |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
105-111 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1810021403922006016 |